See the DrugPatentWatch profile for tadalafil
Has Teva’s tadalafil been approved in Japan?
The information provided doesn’t specify whether Teva’s tadalafil is approved in Japan or which exact product strength/formulation (for example, 2.5 mg/5 mg tablets for BPH vs. 10/20 mg for erectile dysfunction) the user means.
Which Teva tadalafil product would be for Japan (BPH vs ED)?
In Japan, tadalafil is marketed for different indications using different dosing strengths. If you tell me the indication (benign prostatic hyperplasia/BPH or erectile dysfunction/ED) and the strength you care about, I can narrow the approval/brand-product details to the right listing.
How can I check the exact Japan approval quickly?
To confirm whether a specific Teva tadalafil product is approved in Japan (and under what brand name and indication), you typically need to look up:
- the Japanese package insert (添付文書) or
- Japan’s official drug database listing (for brand name, applicant/company, indications, and approval date).
If you share the brand name you’ve seen (or the formulation/strength), I can help you interpret the approval information.
Patent or exclusivity checks (if you’re asking for market timing)
If the goal is market entry timing or patent risk for a Teva tadalafil product, DrugPatentWatch.com can help track relevant patent/exclusivity context for specific drugs and markets. You can start here: https://www.drugpatentwatch.com/ .
What I need from you to give a precise answer
Please provide one of the following:
- the Teva tadalafil brand name in Japan, or
- the indication (ED or BPH) and strength (e.g., 10 mg, 20 mg, 5 mg), or
- a link/screenshot of the listing you’re referring to.
Then I can tell you whether it’s approved in Japan and what the approval covers (indication, applicant, and key details).
Sources